Skip to content

Building Research for Intervention Development in Gliosis and Eating Habits

Fostering Patient-oriented Research in Cardiometabolic Disease Pathogenesis and Prevention

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06870578
Acronym
BRIDGE
Enrollment
75
Registered
2025-03-11
Start date
2025-04-03
Completion date
2029-06-30
Last updated
2025-06-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Child Obesity, Eating, Gliosis

Brief summary

The goal of this study is to 1) use magnetic resonance imaging (MRI) to evaluate the effect of nutritious foods on inflammation in the human hypothalamus of children and 2) assess the feasibility and acceptability of nutritious food feeding intervention strategies in children with overweight or obesity.

Interventions

OTHERDiet modification

In Study 2 only, children will be provided all meals for a 7-day period. Meals will consist of nutritious foods, calories provided will exceed the child's estimated daily caloric need, and children will be asked to consume meals ad libitum.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
University of Washington
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
9 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Study1: Adult caregiver and Child age 9-11y. Willing to come to in-person focus group * Study 2: Age 9-11y, BMI ≥85th and ≤95th percentile for age and sex * Study 3:Adult caregiver with child who qualify for free or reduced-cost lunch in WA State. Child age 9-11y and with overweight.

Exclusion criteria

(study 1 child participants and study 3 criteria for children of adult participants): * Significant health conditions including type 2 diabetes * History of major weight loss or eating disorder * Current use of medications known to alter appetite or body weight (e.g., stimulants for ADHD) * Documented cognitive disorder * Severe food allergies, vegetarian, or vegan (Study 1 only) * Unable to make the session date

Design outcomes

Primary

MeasureTime frame
T2 relaxation time by brain MRI7 days of diet intervention

Countries

United States

Contacts

Primary ContactBRIDGE Study
bridge-study@uw.edu206 616-6360

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026